Where I’d Invest $10,000 Right Now
Listen to the audio version of this article (generated by AI). One of the wildest stock moves last week had nothing to do with AI – until suddenly, it did. Last Wednesday, Moderna, Inc. (MRNA) soared 177% after reporting positive Phase 3 trial results for its personalized mRNA cancer vaccine. The treatment is being developed ...










